23 May 2013
Keywords: ucb, drugs, miss, ph, iia, endpoints, future
Article | 02 March 2009
UCB says that both lacosamide in migraine prophylaxis and rotigotine in fibromyalgia syndrome failed to achieve statistical significance for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
9 March 2009
22 May 2013
© 2013 thepharmaletter.com